Uncategorized
Ophthalmic artery chemosurgery reduces recurrent tumors in genetic retinoblastoma
Eyes undergoing ophthalmic artery chemosurgery for hereditary retinoblastoma had fewer new tumors after radiation or systemic chemotherapy than previously believed, according to a study.The retrospective review included 116 eyes of 81 patients. Forty-one treatment-naïve eyes underwent ophthalmic artery chemosurgery (OAC); 75 eyes underwent OAC after previous treatment with systemic chemotherapy, external beam radiation or both, along with focal techniques.